Project Grant R00HL169908
Award Date 7/24/26
Completion Date 6/30/29
Dollars Obligated $249K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Palo Alto, CA 94304, USA
Similar Awards
- The National Heart, Lung, and Blood Institute, a component of the Department of Health and Human Services National Institutes of Health, awarded $792,498 to the Trustees of Indiana University (doing business as Indiana University Indianapolis) on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate gene-environment interactions in congenital heart disease, specifically the role of maternal obesity in offspring cardiac development. The research...
- The National Heart, Lung, and Blood Institute awarded the Trustees of Indiana University $516,592 on July 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct integrative genomic analysis and develop high-dimensional risk prediction models for congenital heart defects using random field methods. The research leverages existing biospecimens and data from the National Birth Defect Prevention Studies, the Pediatric Cardiac Genomics Consortium, and the Trans-Omics for...
- The National Heart, Lung, and Blood Institute of the Department of Health and Human Services awarded Duke University $1,532,545 on June 5, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to analyze the effect of income-based health insurance benefit designs on cardiovascular disease outcomes and disparities among low-income workers. The research examines whether employers' selective provision of more generous health benefits—such as free cardioprotective medicines or low...
- The National Heart, Lung, and Blood Institute awarded the Trustees of Indiana University $277,375 under the Cardiovascular Diseases Research program (CFDA 93.837) on July 25, 2026, to conduct a cluster randomized controlled trial assessing the feasibility and effect of Health Strides, a six-month, multi-level physical activity intervention targeting Head Start staff. The intervention combines workplace-level and individual-level components. The workplace component establishes a wellness...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Indiana University Indianapolis a Project Grant of $169,444.00 under the Cardiovascular Diseases Research program (CFDA 93.837) beginning September 5, 2025, with completion targeted for August 31, 2030. This award supports the co-development and pilot testing of a stress management intervention designed specifically for Black adults with elevated blood pressure and hypertension. The research addresses...
- The National Heart, Lung, and Blood Institute awarded the University of Denver $169,638 on July 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate neighborhood food access as a predictor of cardiovascular disease risk in early childhood. The project applies a prospective mechanistic approach to test whether limited neighborhood food access associates with obesogenic food-related behaviors and higher cardiovascular disease risk in early childhood. The...
- The National Institutes of Health National Heart, Lung and Blood Institute awarded The Leland Stanford Junior University $165,887 on June 5, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate multi-level drivers of pregnancy-related cardiovascular outcomes across the life-course. The award funds research to elucidate mechanisms by which community disinvestment across the life-course influences perinatal cardiometabolic dysfunction and short- and long-term...
- The National Heart, Lung, and Blood Institute awarded the Trustees of Indiana University $1,484,930 on June 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and validate a behavioral large language model that identifies prescriptions of guideline-directed medical treatments for peripheral artery disease-related claudication in electronic health records. The project addresses suboptimal clinical implementation of proven non-invasive behavioral and pharmacologic...
- The National Heart, Lung, and Blood Institute, a division of the Department of Health and Human Services National Institutes of Health, awarded Duke University $129,399 on January 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct mechanistic research into health disparities driven by the built environment's impact on physical activity and health outcomes. Duke University will leverage longitudinal wearable device data from the All of Us Research Program to...
- The National Institutes of Health National Heart Lung and Blood Institute awarded Brigham & Women's Hospital Inc. $1.789 million on July 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837). The award funds integrative computational-experimental approaches to identify rare coding variants that influence lipid metabolism and cardiovascular disease risk. The research combines large-scale population cohort data with high-throughput functional screening using base and prime...